JP2018532719A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532719A5
JP2018532719A5 JP2018513603A JP2018513603A JP2018532719A5 JP 2018532719 A5 JP2018532719 A5 JP 2018532719A5 JP 2018513603 A JP2018513603 A JP 2018513603A JP 2018513603 A JP2018513603 A JP 2018513603A JP 2018532719 A5 JP2018532719 A5 JP 2018532719A5
Authority
JP
Japan
Prior art keywords
solvent
polymorph
butanol
powder
ray diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018513603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018532719A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/052300 external-priority patent/WO2017049196A1/en
Publication of JP2018532719A publication Critical patent/JP2018532719A/ja
Publication of JP2018532719A5 publication Critical patent/JP2018532719A5/ja
Priority to JP2021083727A priority Critical patent/JP2021121606A/ja
Pending legal-status Critical Current

Links

JP2018513603A 2015-09-18 2016-09-16 抗真菌化合物および作製方法 Pending JP2018532719A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021083727A JP2021121606A (ja) 2015-09-18 2021-05-18 抗真菌化合物および作製方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562220384P 2015-09-18 2015-09-18
US62/220,384 2015-09-18
US201662275504P 2016-01-06 2016-01-06
US62/275,504 2016-01-06
PCT/US2016/052300 WO2017049196A1 (en) 2015-09-18 2016-09-16 Antifungal compounds and processes for making

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021083727A Division JP2021121606A (ja) 2015-09-18 2021-05-18 抗真菌化合物および作製方法

Publications (2)

Publication Number Publication Date
JP2018532719A JP2018532719A (ja) 2018-11-08
JP2018532719A5 true JP2018532719A5 (enExample) 2019-07-25

Family

ID=58289604

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018513579A Expired - Fee Related JP6887993B2 (ja) 2015-09-18 2016-09-16 抗真菌化合物調製方法
JP2018513603A Pending JP2018532719A (ja) 2015-09-18 2016-09-16 抗真菌化合物および作製方法
JP2018514436A Active JP6847458B2 (ja) 2015-09-18 2016-09-16 抗真菌化合物のプロセス
JP2021083727A Pending JP2021121606A (ja) 2015-09-18 2021-05-18 抗真菌化合物および作製方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018513579A Expired - Fee Related JP6887993B2 (ja) 2015-09-18 2016-09-16 抗真菌化合物調製方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018514436A Active JP6847458B2 (ja) 2015-09-18 2016-09-16 抗真菌化合物のプロセス
JP2021083727A Pending JP2021121606A (ja) 2015-09-18 2021-05-18 抗真菌化合物および作製方法

Country Status (17)

Country Link
US (4) US10464921B2 (enExample)
EP (3) EP3349586B1 (enExample)
JP (4) JP6887993B2 (enExample)
KR (3) KR102798709B1 (enExample)
CN (3) CN108289457B (enExample)
AU (3) AU2016323782B2 (enExample)
BR (2) BR112018005198A2 (enExample)
CA (3) CA2998808A1 (enExample)
EA (3) EA036098B1 (enExample)
ES (2) ES2821021T3 (enExample)
HK (3) HK1258863A1 (enExample)
HU (1) HUE053638T2 (enExample)
MX (3) MX391538B (enExample)
PL (1) PL3349586T3 (enExample)
TW (3) TWI723047B (enExample)
WO (3) WO2017049096A1 (enExample)
ZA (1) ZA201801404B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017514790A (ja) 2014-03-19 2017-06-08 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
AU2015231234B2 (en) 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP6606508B2 (ja) 2014-03-19 2019-11-13 マイコヴィア ファーマシューティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
MX371291B (es) 2014-03-19 2020-01-24 Viamet Pharmaceuticals Nc Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procedimientos para su preparacion.
AU2015231220B2 (en) 2014-03-19 2019-04-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Antifungal compound process
JP6572234B2 (ja) 2014-03-19 2019-09-04 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 抗真菌化合物の調製方法
EA037587B1 (ru) 2014-03-19 2021-04-19 Майковиа Фармасьютикалс, Инк. Способ получения противогрибковых соединений
JP6518683B2 (ja) 2014-03-19 2019-05-22 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 抗真菌化合物の調製方法
MX382905B (es) 2014-03-19 2025-03-13 Viamet Pharmaceuticals Nc Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)-3-(1h-tetrazol-1-il)propan-2-oles y procesos para su preparacion.
MX391538B (es) 2015-09-18 2025-03-21 Mycovia Pharmaceuticals Inc Proceso de compuesto antifungico.
CN109666019B (zh) * 2017-10-14 2021-04-06 朱允涛 一种氘代的氮唑醇类化合物及其制备方法和用途
US11213031B2 (en) 2017-11-13 2022-01-04 Bayer Aktiengesellschaft Tetrazolylpropyl derivatives and their use as fungicides
WO2021188404A1 (en) * 2020-03-19 2021-09-23 Assia Chemical Industries Ltd Solid state forms of oteseconazole and process for preparation thereof
US20240398773A1 (en) * 2021-07-22 2024-12-05 Mycovia Pharmaceuticals, Inc. Compositions comprising oteseconazole
CN114573503B (zh) * 2022-03-28 2024-04-09 浙江天宇药业股份有限公司 一种制备奥特康唑中间体的方法
CN114573557B (zh) * 2022-03-28 2024-03-08 浙江天宇药业股份有限公司 一种奥特康唑的制备方法
CN116621816B (zh) * 2022-09-23 2025-07-04 北京莱瑞森医药科技有限公司 一种伏立康唑对映异构对b的拆分方法
WO2024067784A1 (zh) * 2022-09-30 2024-04-04 上海济煜医药科技有限公司 双环类化合物的无定形、结晶固体及其制备方法
CN119798219B (zh) * 2025-01-13 2025-07-18 长治医学院 一种奥特康唑的制备方法

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854015B2 (de) 1978-12-14 1980-10-09 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Herstellung von !H-TetrazoI-1-essigsauren und bestimmter Ester derselben
EP0069442B1 (en) 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
CS228931B2 (cs) 1981-06-06 1984-05-14 Pfizer Způsob výroby 2-(2,4-difluorfenyl)-l,3-bis(lH-l,2,4-triazol-l-yl)propan- -2-oiu
GB8304282D0 (en) 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
ATE107176T1 (de) 1989-12-04 1994-07-15 Searle & Co System zur transdermalen albuterol applikation.
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
JPH07502219A (ja) 1991-12-18 1995-03-09 ミネソタ マイニング アンド マニュファクチャリング カンパニー 多重層型バリアー構造体
ATE132381T1 (de) 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
JP2000344744A (ja) 1999-06-04 2000-12-12 Ss Pharmaceut Co Ltd アセトフェノン誘導体およびその製法
KR20040050906A (ko) * 2001-10-08 2004-06-17 코닌클리케 필립스 일렉트로닉스 엔.브이. 모션 추정을 위한 장치 및 방법
JP2004359646A (ja) 2003-06-09 2004-12-24 Ss Pharmaceut Co Ltd 抗真菌活性を有する新規アゾール誘導体
US7241800B2 (en) 2004-03-17 2007-07-10 Mai De Ltd. Anhydrous amorphous form of fluvastatin sodium
US8198448B2 (en) 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
KR100889937B1 (ko) 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
UA108596C2 (xx) * 2007-11-09 2015-05-25 Інгібітори пептиддеформілази
KR101109215B1 (ko) 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
BRPI1010096A2 (pt) 2009-06-18 2016-03-15 Basf Se compostos de formulas i e ii, composição agrícola, uso de um composto, método de controle de fungos nocivos, semente, composição farmacêutica, uso de um composto e método de tratamento contra o câncer ou infecções por vírus ou para combater a fungos zoopatogênicos ou humanopatogênicos
JP5266430B2 (ja) 2010-04-24 2013-08-21 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 金属酵素阻害化合物
CA2839769A1 (en) 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CA2839691A1 (en) 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
AU2012273007A1 (en) 2011-06-23 2014-01-30 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
TW201329025A (zh) 2011-11-01 2013-07-16 Astex Therapeutics Ltd 醫藥化合物
EP2788343B1 (en) * 2011-12-11 2018-02-28 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
AU2013209516A1 (en) 2012-01-20 2014-08-28 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
EA201491386A1 (ru) 2012-01-20 2014-11-28 Вайамет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
EA201492082A1 (ru) * 2012-06-04 2015-03-31 Фармасайкликс, Инк. Кристаллические формы ингибитора тирозинкиназы брутона
KR20140012226A (ko) * 2012-07-18 2014-02-03 엘지전자 주식회사 태양전지 모듈
WO2014043376A1 (en) 2012-09-12 2014-03-20 Dow Agrosciences Llc Metalloenzyme inhibitor compounds
EP2948450A4 (en) 2013-01-28 2016-11-09 Viamet Pharmaceuticals Inc METALLOENZYMINHIBITORVERBINDUNGEN
US9598340B2 (en) 2013-04-05 2017-03-21 The Regents Of The University Of California Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds
US9447073B2 (en) 2013-05-28 2016-09-20 Viamet Pharmaceuticals, Inc. Fungicidal compositions
EA201690007A1 (ru) 2013-06-12 2016-04-29 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
JP6572234B2 (ja) 2014-03-19 2019-09-04 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 抗真菌化合物の調製方法
JP2017514790A (ja) 2014-03-19 2017-06-08 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
AU2015231234B2 (en) 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
AU2015231220B2 (en) 2014-03-19 2019-04-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Antifungal compound process
MX382905B (es) 2014-03-19 2025-03-13 Viamet Pharmaceuticals Nc Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)-3-(1h-tetrazol-1-il)propan-2-oles y procesos para su preparacion.
MX371291B (es) 2014-03-19 2020-01-24 Viamet Pharmaceuticals Nc Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procedimientos para su preparacion.
JP6518683B2 (ja) * 2014-03-19 2019-05-22 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 抗真菌化合物の調製方法
EA037587B1 (ru) * 2014-03-19 2021-04-19 Майковиа Фармасьютикалс, Инк. Способ получения противогрибковых соединений
AU2015231270B2 (en) 2014-03-19 2019-03-07 Viamet Pharmaceuticals (NC), Inc. Antifungal compound process
JP6606508B2 (ja) 2014-03-19 2019-11-13 マイコヴィア ファーマシューティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
CA2978339C (en) 2015-03-19 2021-08-03 Viamet Pharmaceuticals, Inc. Antifungal compounds and processes for making
WO2016187201A2 (en) 2015-05-18 2016-11-24 Viamet Pharmaceuticals, Inc. Antifungal compounds
MX391538B (es) 2015-09-18 2025-03-21 Mycovia Pharmaceuticals Inc Proceso de compuesto antifungico.
US10513506B2 (en) 2015-11-17 2019-12-24 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl and processes of preparation
CA3005743A1 (en) 2015-11-17 2017-05-26 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
CA3005862A1 (en) 2015-11-17 2017-05-26 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
AR106729A1 (es) 2015-11-17 2018-02-14 Viamet Pharmaceuticals Inc 4-((6-(2-(2,4-difluorofenil)-1,1-difluoro-2-oxoetil)piridin-3-il)oxi)benzonitrilo y proceso para su preparación
WO2017117393A1 (en) 2015-12-30 2017-07-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds

Similar Documents

Publication Publication Date Title
JP2018532719A5 (enExample)
JP6439050B2 (ja) Ask1阻害剤を調製するプロセス
HRP20221113T1 (hr) Antifungalni spojevi i procesi izrade
TWI454464B (zh) 哌衍生物的製備方法
JP2019516692A5 (enExample)
JP2010516681A5 (enExample)
JP2021530565A5 (enExample)
JP2013047248A (ja) インテグラーゼ阻害剤を調製するためのプロセスおよび中間体
JP2018520178A5 (enExample)
WO2016055918A1 (en) Novel stable polymorphs of isavuconazole or its salt thereof
JP2018502909A5 (enExample)
JP2016509042A5 (enExample)
JP6699979B2 (ja) シロドシンおよびその中間体の合成方法ならびに結晶フォーム
JP2006137778A5 (enExample)
JP2010539237A5 (enExample)
JP2015524822A (ja) インテグラーゼインヒビターを調製するためのプロセスおよび中間体
JP2018510914A5 (enExample)
JP2021501127A5 (enExample)
JP2018528948A (ja) アプレミラストの新規形態及びその作成方法
TWI775753B (zh) 製備白克列之方法
TWI756173B (zh) 製備啶醯菌胺之方法
CN106565626B (zh) 2-氨基-4-芳基-5-甲硫基噻唑类化合物的合成方法
JP6490927B2 (ja) カレビンaおよびその生物学的に活性な類似体の合成
JP2017507994A5 (ja) チアクマイシンbの新たな溶媒和結晶
JP2016519669A5 (enExample)